Terminated PHASE2 INTERVENTIONAL 1-arm NCT01928043

Adjunctive Curcumin for Symptomatic Adolescents With Bipolar Disorder: Brain and Body Considerations

Sponsor: Sunnybrook Health Sciences Centre

Interventions Curcumin

Updated 7 times since 2017 Last updated: Jul 20, 2018 Started: Sep 30, 2013 Primary completion: Mar 3, 2017 Completion: Mar 3, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

insufficient recruitment

Other terminated trials from Sunnybrook Health Sciences Centre

See all terminations from Sunnybrook Health Sciences Centre

Other Bipolar Disorder trials with similar outcome

Browse all Bipolar Disorder trials

This PHASE2 trial investigates Bipolar Disorder and is currently terminated or withdrawn. Sunnybrook Health Sciences Centre leads this study, which shows 7 recorded versions since 2013 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Aug 2018 — Jan 2021 [monthly]

Terminated PHASE2

Status: Recruiting → Terminated
Jun 2018 — Aug 2018 [monthly]

Recruiting PHASE2

▶ Show 2 earlier versions

Oct 2017 — Jun 2018 [monthly]

Recruiting PHASE2
Jan 2017 — Oct 2017 [monthly]

Recruiting PHASE2

First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sunnybrook Health Sciences Centre
The Depressive and Bipolar Disorder Alternative Treatment Foundation

Data source: Sunnybrook Health Sciences Centre

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toronto, Canada